Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

NeuroFront Acquires Non-Opioid Neuropathic Pain Killer for $130 Million

publication date: Jul 21, 2022

Hong Kong’s NeuroFront Therapeutics acquired greater China rights to a novel non-opioid neuropathic pain drug from Switzerland’s Novaremed in a $130 million agreement. NeuroFront, a company focusing on innovative CNS drugs, will initially develop NRD.E1 to treat diabetes-related neuropathic pain. It will pay $130 million in option and milestone payments for commercialization and manufacturing rights, plus royalties on sales. The company must exercise its license option no later than completion of the Phase IIb trial of NRD.E1 in PDPN, which will start patient enrollment in the next few weeks. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here


BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here


Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here